Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue HTZ Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares OHI Q1 2026 Earnings EPS Surpasses Estimates Amid Minimal Stock Movement CCNE Q1 2026 Earnings Earnings Beat Expectation as Net Interest Margin Holds Steady CIA Q1 2026 Earnings EPS Miss Triggers Cautious Market Response CPF Q1 2026 Earnings EPS Beats Estimates by 44 Amid Solid Operating Performance